Inhalopédia | Inhalers

Class
- Inhaled corticosteroid (ICS)
Active ingredient
- Fluticasone furoate
Device
- Ellipta®
Inhalers techniques and maintenance
Age
- 12 +
Typical use
- Asthma
  Initial controller
Asthma management principles
- COPD (off-label)
  in addition to a dual bronchodilation (LAMA/LABA) when exacerbating
COPD management principles
Marketed strength
- 100 mcg
- 200 mcg
Number of doses
- 30 doses
Dose indicator
- Yes | Numerical
Usual adult dosage
- Low to medium | 100 mcg – 1 inh QD
  High | 200 mcg – 1 inh QD
  Maximum daily dose: 200 mcg
ICS dosing
Usual pediatric dosage
- 12-17 years
  See adult dosage
ICS dosing
Required inspiratory flow
- > 30 - 60 L/min
  Medium-low internal resistance (R2)
Inspiratory flows
Public coverage
- All provinces | Open/Regular Benefit
Advantages
- Once daily dosing
- Easy handling
- Precise dose counter
Disadvantages
- Expensive
- More dysphonia
- Lip sealing difficult for some older patients
Side effects

Product monograph

Download

Arnuity®